Wuxi Biologics Stock Today

WXXWY Stock  USD 3.47  0.04  1.17%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
WuXi Biologics is trading at 3.47 as of the 28th of March 2024; that is 1.17 percent up since the beginning of the trading day. The stock's open price was 3.43. WuXi Biologics has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for WuXi Biologics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
WuXi Biologics Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the Peoples Republic of China, North America, Europe, and internationally. The company was incorporated in 2014 and is headquartered in Wuxi, China. The company has 2.11 B outstanding shares. More on WuXi Biologics

Moving against WuXi Pink Sheet

  0.92BRK-A Berkshire HathawayPairCorr
  0.9NVO Novo Nordisk AS Financial Report 2nd of May 2024 PairCorr
  0.89NONOF Novo Nordisk ASPairCorr
  0.66REGN Regeneron Pharmaceuticals Financial Report 2nd of May 2024 PairCorr
  0.55SGEN Seagen Inc Financial Report 25th of April 2024 PairCorr
  0.46MCHB Mechanics BankPairCorr
  0.42HMTLF Hitachi MetalsPairCorr

WuXi Pink Sheet Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. WuXi Biologics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding WuXi Biologics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO, Executive DirectorZhisheng Chen
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
WuXi Biologics [WXXWY] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 34.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate WuXi Biologics's market, we take the total number of its shares issued and multiply it by WuXi Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. WuXi Biologics classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 2.11 B outstanding shares. WuXi Biologics has accumulated about 9.86 B in cash with 3.43 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check WuXi Biologics Probability Of Bankruptcy
Ownership Allocation
WuXi Biologics owns a total of 2.11 Billion outstanding shares. Roughly 100.0 (%) of WuXi Biologics outstanding shares are held by general public with 0.007 percent by institutional investors. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check WuXi Ownership Details

WuXi Stock Price Odds Analysis

Based on a normal probability distribution, the odds of WuXi Biologics jumping above the current price in 90 days from now is about 90.88%. The WuXi Biologics probability density function shows the probability of WuXi Biologics pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon WuXi Biologics has a beta of 0.6432. This entails as returns on the market go up, WuXi Biologics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding WuXi Biologics will be expected to be much smaller as well. Additionally, wuXi Biologics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 3.47HorizonTargetOdds Above 3.47
9.09%90 days
 3.47 
90.88%
Based on a normal probability distribution, the odds of WuXi Biologics to move above the current price in 90 days from now is about 90.88 (This WuXi Biologics probability density function shows the probability of WuXi Pink Sheet to fall within a particular range of prices over 90 days) .

WuXi Biologics Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. WuXi Biologics market risk premium is the additional return an investor will receive from holding WuXi Biologics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in WuXi Biologics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although WuXi Biologics' alpha and beta are two of the key measurements used to evaluate WuXi Biologics' performance over the market, the standard measures of volatility play an important role as well.

WuXi Stock Against Markets

Picking the right benchmark for WuXi Biologics pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in WuXi Biologics pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for WuXi Biologics is critical whether you are bullish or bearish towards WuXi Biologics at a given time. Please also check how WuXi Biologics' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in WuXi Biologics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run CEOs Directory Now

   

CEOs Directory

Screen CEOs from public companies around the world
All  Next Launch Module

WuXi Biologics Corporate Directors

WuXi Biologics corporate directors refer to members of a WuXi Biologics board of directors. The board of directors generally takes responsibility for the WuXi Biologics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of WuXi Biologics' board members must vote for the resolution. The WuXi Biologics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Wo FongNon-Executive Independent DirectorProfile
TehMing KwaukNon-Executive Independent DirectorProfile
Edward HuNon-Executive DirectorProfile
Yanling CaoNon-Executive DirectorProfile

How to buy WuXi Pink Sheet?

Before investing in WuXi Biologics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in WuXi Biologics. To buy WuXi Biologics stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of WuXi Biologics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase WuXi Biologics stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located WuXi Biologics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased WuXi Biologics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as WuXi Biologics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in WuXi Biologics?

The danger of trading WuXi Biologics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of WuXi Biologics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than WuXi Biologics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile WuXi Biologics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in WuXi Biologics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for WuXi Pink Sheet analysis

When running WuXi Biologics' price analysis, check to measure WuXi Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WuXi Biologics is operating at the current time. Most of WuXi Biologics' value examination focuses on studying past and present price action to predict the probability of WuXi Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WuXi Biologics' price. Additionally, you may evaluate how the addition of WuXi Biologics to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stocks Directory
Find actively traded stocks across global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Please note, there is a significant difference between WuXi Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if WuXi Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WuXi Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.